Today: 18 July 2026
Browse Category

NASDAQ:VRTX 27 June 2025 - 11 July 2026

Vertex Pharmaceuticals (VRTX) Stock Week Ahead: Holiday-Shortened Trading, New Gene-Therapy Data, and Fresh Analyst Targets (Dec. 22–26, 2025)

Vertex Pharmaceuticals (VRTX) Stock Week Ahead: Holiday-Shortened Trading, New Gene-Therapy Data, and Fresh Analyst Targets (Dec. 22–26, 2025)

Vertex Pharmaceuticals Incorporated heads into the week of December 22–26, 2025 with a familiar setup for biotech investors: a cash-rich market leader in cystic fibrosis, a pipeline that could meaningfully diversify revenue over the next 12–24 months, and a stock that can move quickly on headlines—even when broader markets are quiet.
22 December 2025
Vertex Pharmaceuticals (VRTX) Stock News, Forecasts and Analyst Outlook on Dec. 20, 2025: Casgevy Pediatric Data, Kidney Pipeline Momentum, and Journavx Launch Watch

Vertex Pharmaceuticals (VRTX) Stock News, Forecasts and Analyst Outlook on Dec. 20, 2025: Casgevy Pediatric Data, Kidney Pipeline Momentum, and Journavx Launch Watch

December 20, 2025 — Vertex Pharmaceuticals Incorporated heads into the year’s final stretch with investors focused on a familiar question: can the biotech’s next wave of launches and late-stage programs begin to meaningfully diversify a cystic fibrosis business that has dominated its revenue for more than a decade?
Vertex Pharmaceuticals (VRTX) Stock: This Week’s News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Vertex Pharmaceuticals (VRTX) Stock: This Week’s News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Vertex Pharmaceuticals Incorporated finished Friday at $452.04, extending a late-week rebound after a choppy start to the week. The stock’s intraday range on Friday stretched from $442.94 to $455.99 on volume of about 1.62 million shares, as biotech investors weighed fresh pipeline headlines, Wall Street price-target moves, and a shifting macro backdrop following the Federal Reserve’s latest rate decision. MarketWatch+1
Martian Life Clues, Hawking Vindication, and More – Science News Roundup (Sept 11–12, 2025)

Martian Life Clues, Hawking Vindication, and More – Science News Roundup (Sept 11–12, 2025)

Possible life on Mars – “potential biosignatures”: NASA’s Perseverance rover has uncovered one of the most tantalizing clues yet that Mars may have hosted ancient life. Scientists reported that a sample of fine-grained, iron-rich mudstone rock from Jezero Crater contains minerals that on Earth often form due to microbial activity reuters.com. The rover team spent a year analyzing data from the rock, nicknamed “Sapphire Canyon,” before announcing what they call a “potential biosignature” – a chemical or textural signal that could have a biological origin reuters.com. The rock, which dates back ~3.6 billion years to when Jezero held a lake, has unusual ring-shaped and speckled features resembling “leopard spots” and “poppy seeds” reuters.com. Those could have been produced by chemical reactions involving microbes as the sediment turned to stone. Sean Duffy, NASA’s acting administrator, hailed the find: after exhaustive checks, “we can’t find another explanation, so this very well could be the clearest sign of life that we’ve ever found on Mars – which is incredibly exciting” reuters.com. Officials were quick to caution that this is not proof of life, as non-biological processes might explain the signals reuters.com reuters.com. The rover has sealed the intriguing sample for a future mission
12 September 2025
June 2025 Science Breakthroughs and Projects: Medicine, Space, Climate, AI & More

June 2025 Science Breakthroughs and Projects: Medicine, Space, Climate, AI & More

June 2025 has been a landmark month for science, with breakthroughs across medicine, space exploration, climate science, physics, artificial intelligence, energy, biology, and more. This comprehensive report reviews the latest scientific news from June 2025 and looks ahead to major projects and trends for the remainder of 2025. We cover recent discoveries and studies, provide context and expert insights, and highlight what to watch in the coming months.
Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

The first half of 2025 has seen biotechnology and health technology sectors accelerate on multiple fronts, from groundbreaking scientific advances to robust deal-making. Industry optimism is high – a Deloitte survey of 150 life science executives found 75% believe 2025 will be a strong year, citing anticipated revenue growth and rapid innovation genengnews.com. This optimism is translating into action, with emerging technologies like gene editing, precision medicine, digital health, and AI reaching new milestones. Meanwhile, global market projections remain bullish: for example, the AI in healthcare market is projected to grow about 10-fold from ~$15 billion in 2024 to over $164 billion by 2030 globenewswire.com, and the digital health market is expected to soar past $1 trillion by the early 2030s precedenceresearch.com.
Go toTop